Skip to content
healthcare.dev

Clindamycin Phosphate 1.2% and Tretinoin 0.025%

NDC 68682-300, clindamycin phosphate and tretinoin, gel, from Oceanside Pharmaceuticals.

Product NDC
68682-300
Status
Listed
Labeler
Oceanside Pharmaceuticals
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA050802
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68682-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CLINDAMYCIN PHOSPHATE12 mg/g
  • TRETINOIN.25 mg/g

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Lincosamide Antibacterial [EPC]; Lincosamides [CS]; Neuromuscular Blockade [PE]; Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
68682-300-30686820300301 TUBE in 1 CARTON (68682-300-30) / 30 g in 1 TUBE
68682-300-60686820300601 TUBE in 1 CARTON (68682-300-60) / 60 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/63b2e85d-8fe5-4f18-9e85-8492c49a7520

Use it

Look up 68682-300 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68682-300 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68682-300. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.